GW Pharma beats projections with $108M in Q4 sales thanks to CBD drug
A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana.
News January 13A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana.
News January 13An opportunity to exclusively operate New Brunswick’s recreational cannabis retail, wholesale and e-commerce platforms has drawn interest from…
News January 13Marijuana Business Daily donated more than $425,000 in cash and in-kind donations through its Industry Giveback Program in…
News January 13Marijuana businesses in the United States and Canada were forced to let go hundreds of cannabis employees in…
News January 11Toronto-based Avicanna - which has cultivation operations in Colombia - on Friday announced an agreement with Shoppers Drug Mart…
News January 10British Columbia’s monthly share of the federal tax on cannabis rebounded 62% to 781,000 Canadian dollars ($600,000) for…
News January 10The price offered by the winner of the first bidding process to supply medical cannabis in Peru came…
News January 9British Columbia has thus far failed to transition much of the thriving noncompliant cannabis market into the regulated…
News January 8The volume of beer sold in Canada declined 3% in the first 11 months of 2019 compared to…
News January 7The number of Canadian cannabis producers with fewer than six months of cash on hand has increased over…
News January 7